Homologous Recombination Repair Testing Patterns and Outcomes in mCRPC by Alteration Status and Race
Mehmet Asim Bilen,1 Ibrahim Khilfeh,2 Carmine Rossi,3 Erik Muser,2 Laura Morrison,3 Annalise Hilts,3 Lilian Diaz,3 Patrick Lefebvre,3 Dominic Pilon,3 Daniel J George4 1Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA; 2Janssen Scientific Affairs, L...
Saved in:
Main Authors: | Bilen MA (Author), Khilfeh I (Author), Rossi C (Author), Muser E (Author), Morrison L (Author), Hilts A (Author), Diaz L (Author), Lefebvre P (Author), Pilon D (Author), George DJ (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients With mCRPC Treated With Abiraterone
by: Cristian Lolli, et al.
Published: (2016) -
Very Early PSA Response to Abiraterone in mCRPC Patients: a Novel Prognostic Factor Predicting Overall Survival
by: Gaetano eFacchini, et al.
Published: (2016) -
Development of [<sup>225</sup>Ac]Ac-PSMA-I&T for Targeted Alpha Therapy According to GMP Guidelines for Treatment of mCRPC
by: Eline L. Hooijman, et al.
Published: (2021) -
Efficacy and Safety of [<sup>225</sup>Ac]Ac-PSMA-617 Augmented [<sup>177</sup>Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Highly Advanced mCRPC with Poor Prognosis
by: Florian Rosar, et al.
Published: (2021) -
Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer
by: David Gonzalez, et al.
Published: (2021)